Integral Derivatives’s Denbury Resources, Inc. DNR Stock Holding History

Integral Derivatives’s Portfolio DNR Stock Details DNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-28,700	Closed	-$45.1K	–	1345
2017 Q3	$38K	Buy	+28,700	New	+$37.4K	﹤0.01%	1102
2015 Q2	–	Sell	-19,300	Closed	-$141K	–	1318
2015 Q1	$141K	Buy	+19,300	New	+$150K	﹤0.01%	986

Other funds holding DNR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

SCP

SailingStone Capital Partners Houston, Texas $534M AUM 51.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Integral Derivatives's DNR Position: Q4 2017 in Review

Integral Derivatives sold out of Denbury Resources, Inc. (DNR) in Q4 2017, closing a stake of 28,700 shares — an estimated $45.1K sold.

Integral Derivatives first reported a position in DNR in Q1 2015 and held it in 2 quarters. The position peaked at $141K in Q1 2015. 193 funds tracked by Wall St. Rank hold DNR as of Q4 2017.

Integral Derivatives reported no remaining Denbury Resources, Inc. position as of Q4 2017 after selling out during the quarter.
Integral Derivatives sold 28,700 Denbury Resources, Inc. shares in Q4 2017, an estimated $45.1K.
Integral Derivatives first reported a position in Denbury Resources, Inc. in Q1 2015 and held it in 2 quarters.
Integral Derivatives's Denbury Resources, Inc. position peaked at $141K in Q1 2015.
193 funds tracked by Wall St. Rank held Denbury Resources, Inc. as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.